Safety of tabelecleucel with pembrolizumab in recurrent/metastatic Epstein-Barr virus-associated nasopharyngeal carcinoma Meeting Abstract
| Authors: | Colevas, A. D.; Cohen, R. B.; Park, J. C.; Pfister, D. G.; Massarelli, E.; Li, Z.; Xing, B.; Dinavahi, R.; Mehta, A. |
| Abstract Title: | Safety of tabelecleucel with pembrolizumab in recurrent/metastatic Epstein-Barr virus-associated nasopharyngeal carcinoma |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557401554 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.6096 |
| Notes: | Meeting Abstract: 6096 -- Source: Wos |
